EUVIMEDEUVIMED entdecken
Crossref

Immunohistochemical Evaluation of COL11A1 and FGD3 Expression in Invasive Breast Cancer

Tommaso Susini, Irene Renda, Milo Giani, Vania Vezzosi, Gianna Baroni, Simonetta Bianchi

Medical Research Archives · 28.02.2023 · 11 (2)

DOI: 10.18103/mra.v11i2.3593 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 28.02.2023. Verfasst von Tommaso Susini und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Collagen type XI, alpha 1 (COL11A1) is a minor component of extracellular matrix and its overexpression is associated with tumoral progression and poorer outcome in several human cancers; data on breast cancer are promising but scarce. FGD3 expression has been shown to be a strong independent prognostic factor in breast cancer. The aim of our study was to investigate whether COL11A1 expression correlates with other classic pathologic prognostic factors including FGD3 expression, as well as with clinical outcome, to evaluate its potential use as prognostic factor in breast cancer patients.

Methods

We evaluated by immunohistochemistry COL11A1 expression and we studied the relationship between this protein expression and traditional breast cancer prognostic factors, FGD3 expression, as well as with patients’ outcome.

Results

We found that higher stromal COL11A1 expression was associated with higher tumour grade (G3) (p = 0.001), higher Ki67 proliferation index (p = 0.006), more advanced AJCC stage (p = 0.031) and lower FGD3 expression (p = 0.039). In a case-control analysis, we observed that patients with high-COL11A1 had a higher risk of recurrence (OR = 2.0) and of dying of the disease (OR = 2.0). Patients with high-COL11A1-expressing tumours had shorter disease-free survival and overall survival (difference not significant). There was a linear positive correlation between COL11A1 expression on epithelial tumoral cells and surrounding stromal cells (r = 0.247, p = 0.04).

Conclusion

Our findings suggest that COL11A1 may represent a marker of aggressiveness in invasive breast cancer and that its detection warrants further study on larger series to evaluate its possible use in clinical practice.

Zitieren

APA

Susini, T., Renda, I., Giani, M., Vezzosi, V., Baroni, G., & Bianchi, S. (2023). Immunohistochemical Evaluation of COL11A1 and FGD3 Expression in Invasive Breast Cancer. Medical Research Archives, 11(2). https://doi.org/10.18103/mra.v11i2.3593

Vancouver

Susini T, Renda I, Giani M, Vezzosi V, Baroni G, Bianchi S. Immunohistochemical Evaluation of COL11A1 and FGD3 Expression in Invasive Breast Cancer. Medical Research Archives. 2023;11(2). doi:10.18103/mra.v11i2.3593

BibTeX
@article{Susini2023,
  author = {Susini, Tommaso and Renda, Irene and Giani, Milo and Vezzosi, Vania and Baroni, Gianna and Bianchi, Simonetta},
  title = {Immunohistochemical Evaluation of COL11A1 and FGD3 Expression in Invasive Breast Cancer},
  journal = {Medical Research Archives},
  year = {2023},
  volume = {11},
  number = {2},
  doi = {10.18103/mra.v11i2.3593}
}
Kostenlos starten →